Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00080470 · ClinicalTrials.gov registry record · Phase 3
An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence
A Phase 3 study of Urinary Incontinence, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- Phase 3
- Development phase
- 148
- Enrollment target
- 11
- Study locations
NCT00080470 is a Phase 3 study of Urinary Incontinence that has completed, run by Boston Scientific Corporation. The registered enrollment target is 148 participants, below the 259-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (43% lower). The trial reports 11 study locations across 10 states.
The verdict
NCT00080470, a Phase 3 study of Urinary Incontinence, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 148 participants
- Enrollment target
- 11
- Study locations
Study Summary
This clinical trial is being conducted to investigate the safety and effectiveness of a new device designed to treat urinary urge incontinence in those patients who have tried and failed two or more conservative therapies.
Conditions Studied
Interventions
- DEVICE bion
Study Locations (11)
Texas
- Dallas Center for Pelvic Medicine - Dallas
- Baylor College of Medicine - Houston
Arizona
- Arizona Health Sciences Center (University of Arizona) - Tucson
California
- The Department of Urology, Stanford University Medical Center - Stanford
Colorado
- Milestone Medical Research - Englewood
Connecticut
- Bladder Control Center of Norwalk - Norwalk
District of Columbia
- Walter Reed Army Medical Center, Division of Pelvic Medicine and Reconstructive Surgery - Washington D.C.
Michigan
- William Beaumont Hospital - Royal Oak
Minnesota
- Cornerstone Medical Specialty Center - Woodbury
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 148 participants |
| Start Date | 2003-06 |
| Est. Completion | 2012-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00080470
The ClinicalTrials.gov registry entry for NCT00080470 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 148 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 259-participant average among 48 other Urinary Incontinence trials with a reported enrollment target (43% lower). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which bion is the first listed.
NCT00080470 reports 11 study locations spanning 10 distinct geographic areas - top geographies include Texas, Arizona, California.
Frequently Asked Questions
What is clinical trial NCT00080470 about?
NCT00080470 is a clinical study titled "An Implantable Microstimulator for the Chronic Treatment of Refractory Urinary Urge Incontinence". This clinical trial is being conducted to investigate the safety and effectiveness of a new device designed to treat urinary urge incontinence in those patients who have tried and failed two or more conservative therapies.
What is the current status of trial NCT00080470?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 148 participants. The study started on 2003-06. Estimated completion is 2012-12.
What conditions does trial NCT00080470 study?
This clinical trial studies the following conditions: Urinary Incontinence.
What interventions are being tested in trial NCT00080470?
The interventions under investigation include: bion (DEVICE).
Who is sponsoring clinical trial NCT00080470?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00080470 being conducted?
This trial has 11 study locations across Arizona, California, Colorado, Connecticut, District of Columbia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Self-Care to Prevent Birth-Related Urinary Incontinence in Diverse Women
COMPLETED · Phase 3
-
NXT Post-Market Clinical Follow-up
RECRUITING
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
TENS Analgesia During Outpatient Urethral Bulking for Stress Urinary Incontinence.
RECRUITING · NA
-
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
RECRUITING · NA
-
Improving Overactive Bladder Treatment Access and Adherence
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.